drug
apixaban ER
Preclinicalupdated 3mo agoby Taho Pharmaceuticals Ltd
Preclinicalcommunity read0 votes
🐶 often sniffed alongside
top 8- drugapixaban5 co-mentions · 2 sources
- drugapixaban ODT5 co-mentions · 2 sources
- tagOncology2 co-mentions · 1 sources
- tagHematology2 co-mentions · 1 sources
- tagAdCom2 co-mentions · 1 sources
- tag510(k) Clearance2 co-mentions · 1 sources
- tagDiagnostics Company2 co-mentions · 1 sources
- companyMedical University of Gdansk1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying apixaban ER
- phase3Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
- phase2Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- phase3A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
- N/ADEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
- phase1A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants
- phase3REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
- —Anticoagulation in Patients With Venous Thromboembolism and Cancer
- —High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that